← All stocks

Vor Biopharma Inc.

VOR No buying or selling
CIK 0001817229 #2313 in the set updated 19 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$0.00
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$0.00
0 of 0 sales
Net
$0.00
$0.00 against sales at will

By person

9 insiders · 1 transaction
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Reprogrammed Interchange LLC entity
10% owner
1,166,909
$23.05M
Zuraw Qing Che
Chief Development Officer
937,080
$18.51M
ANG ROBERT
PRESIDENT AND CEO
911,318
$18.00M
+15.0%
Chakraborty Tirtha
Chief Sci Off & Head Tech Ops
217,416
$4.29M
+26.6%
Attar Eyal C.
CHIEF MEDICAL OFFICER
126,625
$2.50M
+34.8%
Choi Han Wook
Chief Financial Officer
51,280
$1.01M
+5,998%
Quinlan Amy
Vice President of Finance
50,312
$993.66K
−1.1%
RA CAPITAL MANAGEMENT, L.P. entity
10% owner
1,500
$29.63K
Mahatme Sandesh
CFO
0
$0.00

No percentages here. This company's share count has moved by a factor of 12.2 over the window, from 10,410,630 to 126,683,111 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Insider
Date
Role
Action
Shares
Price
Amount
RA CAPITAL MANAGEMENT, L.P.
24 Aug 2026
10% owner
Exercised, kept indirect
1,500
$3.74
$5.60K

What was left out

Form 4 filings counted 1
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 1,500
History held since 9 Feb 2021